Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathy SEATTLE, September 23, 2025--(BUSINESS ...
The Gates Foundation announced Tuesday that it is pledging $1.6 billion over five years to Gavi, the Vaccine Alliance. Gavi CEO Sania Nishtar reported that the nonprofit has vaccinated 1.1 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback